eribulin advanz pharma 0.44 mg/ml solution for injection
advanz pharma limited - eribulin mesylate - solution for injection - eribulin
eribulin advanz pharma 0.44 mg/ml inj. sol. i.v. vial
advanz pharma ltd. - eribulin mesylate 0,5 mg - eq. eribulin 0,44 mg - solution for injection - eribulin
cyclizine 50mg tablets
advanz pharma - cyclizine hydrochloride - oral tablet - 50mg
ocaliva
advanz pharma limited - obeticholic acid - liver cirrhosis, biliary - bile and liver therapy - ocaliva is indicated for the treatment of primary biliary cholangitis (also known as primary biliary cirrhosis) in combination with ursodeoxycholic acid (udca) in adults with an inadequate response to udca or as monotherapy in adults unable to tolerate udca.
ciprofibrate 100mg tablets
advanz pharma - ciprofibrate - oral tablet - 100mg
trifluoperazine 1mg tablets
advanz pharma - trifluoperazine hydrochloride - oral tablet - 1mg
trazodone 50mg capsules
advanz pharma - trazodone hydrochloride - oral capsule - 50mg
olena 20mg dispersible tablets
advanz pharma - fluoxetine hydrochloride - dispersible tablet - 20mg
hydrocortisone 20mg tablets
advanz pharma - hydrocortisone - oral tablet - 20mg
hydrocortisone 10mg tablets
advanz pharma - hydrocortisone - oral tablet - 10mg